| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.0043 | 1 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.0028 | 1 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |